Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience

BackgroundDedifferentiated liposarcoma (DDLPS) is one of the most common types of soft tissue sarcoma (STS) characterized by liposarcomatous differentiation and a predilection for the retroperitoneum. Despite the growing number of histology-specific immune checkpoint blockade (ICB) trials in STS, it...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Madeline B. Torres, Cheuk Hong Leung, Marianne Zoghbi, Rossana Lazcano, Davis Ingram, Khalida Wani, Emily Z. Keung, M. Alejandra Zarzour, Christopher P. Scally, Kelly K. Hunt, Anthony Conley, Andrew J. Bishop, B. Ashleigh Guadagnolo, Ahsan Farooqi, Devarati Mitra, Alison K. Yoder, Michael S. Nakazawa, Dejka Araujo, Andrew Livingston, Ravin Ratan, Shreyaskumar Patel, Vinod Ravi, Alexander J. Lazar, Christina L. Roland, Neeta Somaiah, Elise F. Nassif Haddad
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-04-01
Subjects:	sarcoma dedifferentiated liposarcoma Anti-PD1 immunotherapy immune-checkpoint inhibitors survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1567736/full